CASP8 and neoplasm: The observed upregulation of caspase-8 in AC-AFPK-IsCT1–cisplatin-treated cells suggests that the extrinsic pathway may also be involved in the observed cytotoxicity, which might be of interest in tumor cells resistant to intrinsic pathway activation alone [31].